** Shares of medical software firm Omnicell OMCL.O rise 10.3% to $30.15
** OMCL expects 2025 adj. profit forecast in the range of $1.30 to $1.65 per share, compared with previously projected range of $1 to $1.65
** "The updated guidance ranges assume that the potential tariff rate on imports from China returns to 145% after the temporary 90-day reduction period," the company says
** Each 25% reduction below a 145% tariff rate, beginning August 12, represents an expected about $2 million reduction of the impact from the duties on profitability in 2025 - company
** Company expects Q2 adj profit between 24 cents and 34 cents per share vs analysts' estimates 30 cents - data compiled by LSEG
** Company also approved a $75 million stock repurchase program
** Including session's moves, stock down 33.9% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.